The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.
Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...
Goldman Sachs has dropped a target to have black bankers make up 7pc of its London workforce following Donald Trump’s crusade ...
British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...
GSK said it is dropping its diversity and inclusion targets, joining a growing list of companies retreating from initiatives to diversify their workforces and leadership teams amid a legal and ...
One of the lowest paid CEOs in pharma—and the only woman leading a top-tier giant—is set to receive up to $27.2 million in ...
Ieq Capital LLC grew its position in shares of GSK plc (NYSE:GSK – Free Report) by 10.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange ...
Drugmakers and analysts fear retaliation from Brussels will only exacerbate Europe’s drug supply issues. After raising ...
Teos' Belrestotug shows efficacy in trials, backed by a strong cash runway. Learn why ITOS stock might thrive with strategic ...
GSK boss Walmsley (left) received £10.6m in salary and bonuses in 2024 while Blanc (right), head of insurance group Aviva, ...
Announced rosnilimab, a PD-1 depleter and agonist, achieved positive results from Phase 2b rheumatoid arthritis (RA) trial and highest-ever reported CDAI LDA response over 6 monthsFull clinical and tr ...
Containing fake, counterfeit drugs still a long way to go HEART-RENDING as these accounts by relatives of victims appear, ...